← Open Payments lookup

MICHAEL AMENTA: Open Payments

NPI 1225511223 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$255 in 13 payments from 6 companies in 2025. Trend: 2023 $271 · 2024 $150 · 2025 $255

Food & beverage: $255
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc2$58
E.R. Squibb & Sons, L.L.C.3$55
Alkermes, Inc.3$50
Otsuka America Pharmaceutical, Inc.2$37
Teva Pharmaceuticals USA, Inc.2$37
ABBVIE INC.1$18

Products named: INVEGA SUSTENNA, COBENFY, ABILIFY MAINTENA, UZEDY, VRAYLAR, ARISTADA, LYBALVI, VIVITROL.

Industry payments across NE — which companies pay providers there.